Coagulation Disorders in Diabetes

Diabetes is often associated with coagulation disorders, increasing the risk of thromboembolic events such as stroke and heart attack. The hyperglycemic state can lead to endothelial dysfunction and a pro-inflammatory environment, promoting platelet activation and coagulation. Diabetic patients may exhibit altered levels of coagulation factors, contributing to a heightened risk for complications. Management strategies include tight glycemic control, regular monitoring of coagulation parameters, and possibly anticoagulant therapy. Understanding the mechanisms behind coagulation abnormalities in diabetes is essential for improving patient outcomes and preventing cardiovascular complications.

Committee Members
Speaker at Diabetes  2026 - Mahir Khalil Ibrahim Jallo

Mahir Khalil Ibrahim Jallo

Gulf Medical University, Canada
Speaker at Diabetes  2026 - F Buck Willis

F Buck Willis

Christian College of Medicine, Belize
Speaker at Diabetes  2026 - Anil Harrison

Anil Harrison

Midwestern University, United States
Speaker at Diabetes  2026 - Wan Rosli Wan Ishak

Wan Rosli Wan Ishak

Universiti Sains Malaysia, Malaysia
Diabetes 2026 Speakers
Speaker at Diabetes  2026 - Mahir Khalil Ibrahim Jallo

Mahir Khalil Ibrahim Jallo

Gulf Medical University, Canada
Speaker at Diabetes  2026 - F Buck Willis

F Buck Willis

Christian College of Medicine, Belize
Speaker at Diabetes  2026 - Anil Harrison

Anil Harrison

Midwestern University, United States
Speaker at Diabetes  2026 - David Navazio

David Navazio

Gentell, United States
Speaker at Diabetes  2026 - Sujith Rajan

Sujith Rajan

NYU Long Island School of Medicine, United States
Speaker at Diabetes  2026 - David Petch

David Petch

utR Biotech, Canada
Tags

Submit your abstract Today

YouTube
WhatsAppWhatsApp